R. Lariviere et al., EFFECTS OF LOSARTAN AND CAPTOPRIL ON ENDOTHELIN-1 PRODUCTION IN BLOOD-VESSELS AND GLOMERULI OF RATS WITH REDUCED RENAL MASS, American journal of hypertension, 11(8), 1998, pp. 989-997
Recently, we have reported that endothelin-1 (ET-1) production is incr
eased in blood vessels and glomeruli of rats with chronic renal failur
e. This study was design to investigate the role of angiotensin II (An
g II) in endogenous ET-1 production in rats with reduced renal mass. O
ne week after subtotal (5/6) nephrectomy, uremic rats were divided int
o three groups, and received either no treatment, the Ang II subtype 1
receptor (AT(1)) antagonist losartan (10 mg/kg/day), or the angiotens
in-converting enzyme inhibitor (ACE-I) captopril (30 mg/kg/day) for 6
weeks. Sham-operated rats were used as controls and received no treatm
ent. The levels of immunoreactive ET-1 (ir-ET-1) in plasma and urine,
as well as in vascular and renal tissues, were determined by radioimmu
noassay (RIA) after extraction. In uremic rats, losartan and captopril
completely prevented the increase in systolic blood pressure. At week
6, plasma ir-ET-l was similar in the different groups of uremic rats
and in the controls. However, ir-ET-1 concentration in the mesenteric
arterial bed, the thoracic aorta, preglomerular arteries, and glomerul
i, as well as urinary ir-ET-1 excretion were significantly greater in
uremic-untreated rats compared to controls (P <.01). Treatment of urem
ic rats with losartan or captopril reduced ir-ET-1 concentration in th
e thoracic aorta and preglomerular arteries (P <.05), but ir-ET-l conc
entration in the mesenteric arterial bed was unchanged. Although both
drugs completely prevented the increase in proteinuria, losartan but n
ot captopril significantly reduced ir-ET-l concentration in glomeruli
(P <.05) and normalized urinary ir-ET-l excretion. This indicates that
increased ET-1 production in blood vessels and glomeruli of uremic ra
ts is modulated, at least in part by Ang II through the AT(1) receptor
. The beneficial effects of the AT(1) antagonist losartan could be att
ributable to the attenuation of Ang II-induced ET-1 production in this
rat remnant kidney model of chronic renal failure, whereas those of t
he ACE-I captopril are not related to changes in ET-1 production in gl
omeruli. Am J Hypertens 1998;11:989-997 (C) 1998 American Journal of H
ypertension, Ltd.